Načítá se...

Cost‐Effectiveness of Combination Therapy for Patients With Systemic Sclerosis–Related Pulmonary Arterial Hypertension

BACKGROUND: To evaluate the cost‐effectiveness of combination pulmonary arterial hypertension specific therapy in systemic sclerosis–related PAH. METHODS AND RESULTS: Health outcomes and costs were captured through data linkage. Health utility was derived from Medical Outcomes Study Short Form‐36 sc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Heart Assoc
Hlavní autoři: Tran‐Duy, An, Morrisroe, Kathleen, Clarke, Philip, Stevens, Wendy, Proudman, Susanna, Sahhar, Joanne, Nikpour, Mandana
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2021
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8174376/
https://ncbi.nlm.nih.gov/pubmed/33759539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.015816
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!